QVA149
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND
Three classes of inhaler medications are used to manage chronic obstructive pulmonary disease (COPD): long-acting beta…
Background The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one…
RATIONALE
Current Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy recommends the combination of two long…
We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its monocomponents indacaterol and…
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and glycopyrronium, on direct patient-reported…
Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). Long-acting muscarinic…
ABSTRACT This study assessed the cardiovascular safety of QVA149, an inhaled, once daily, bronchodilator combination containing…
Background This randomised, double-blind, placebo controlled, four-period crossover study assessed the efficacy and safety of…